396 related articles for article (PubMed ID: 24950770)
1. Chronic pain patients' treatment preferences: a discrete-choice experiment.
Mühlbacher AC; Junker U; Juhnke C; Stemmler E; Kohlmann T; Leverkus F; Nübling M
Eur J Health Econ; 2015 Jul; 16(6):613-28. PubMed ID: 24950770
[TBL] [Abstract][Full Text] [Related]
2. Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.
Mühlbacher AC; Nübling M
Eur J Health Econ; 2011 Jun; 12(3):193-203. PubMed ID: 20107856
[TBL] [Abstract][Full Text] [Related]
3. Reduce mortality risk above all else: a discrete-choice experiment in acute coronary syndrome patients.
Mühlbacher AC; Bethge S
Pharmacoeconomics; 2015 Jan; 33(1):71-81. PubMed ID: 25342231
[TBL] [Abstract][Full Text] [Related]
4. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment.
Turk D; Boeri M; Abraham L; Atkinson J; Bushmakin AG; Cappelleri JC; Hauber B; Klein K; Russo L; Viktrup L; Walsh D
Osteoarthritis Cartilage; 2020 Sep; 28(9):1202-1213. PubMed ID: 32652238
[TBL] [Abstract][Full Text] [Related]
5. A protocol for a discrete choice experiment: understanding patient medicine preferences for managing chronic non-cancer pain.
Shanahan M; Larance B; Nielsen S; Cohen M; Schaffer M; Campbell G
BMJ Open; 2019 Aug; 9(8):e027153. PubMed ID: 31377695
[TBL] [Abstract][Full Text] [Related]
6. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
8. What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.
Mühlbacher A; Bethge S
Eur J Health Econ; 2016 Dec; 17(9):1125-1140. PubMed ID: 26682548
[TBL] [Abstract][Full Text] [Related]
9. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
Roth T; van Seventer R; Murphy TK
Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
[TBL] [Abstract][Full Text] [Related]
10. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
Front Public Health; 2021; 9():653450. PubMed ID: 33842426
[No Abstract] [Full Text] [Related]
11. Oral or Topical Pain Therapy-How Would Patients Decide? A Discrete Choice Experiment in Patients with Peripheral Neuropathic Pain.
Schubert T; Kern KU; Schneider S; Baron R
Pain Pract; 2021 Jun; 21(5):536-546. PubMed ID: 33342078
[TBL] [Abstract][Full Text] [Related]
12. Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia.
Vinik A; Emir B; Parsons B; Cheung R
Pain Med; 2014 Apr; 15(4):661-70. PubMed ID: 24330406
[TBL] [Abstract][Full Text] [Related]
13. Examining the Time to Improvement of Sleep Interference With Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy and Postherpetic Neuralgia.
Parsons B; Emir B; Knapp L
Am J Ther; 2015; 22(4):257-68. PubMed ID: 25272094
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
[TBL] [Abstract][Full Text] [Related]
15. Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting.
Athanasakis K; Petrakis I; Karampli E; Vitsou E; Lyras L; Kyriopoulos J
BMC Neurol; 2013 Jun; 13():56. PubMed ID: 23731598
[TBL] [Abstract][Full Text] [Related]
16. Development of a Discrete-Choice Experiment (DCE) to Elicit Adolescent and Parent Preferences for Hypodontia Treatment.
Barber S; Bekker H; Marti J; Pavitt S; Khambay B; Meads D
Patient; 2019 Feb; 12(1):137-148. PubMed ID: 30367434
[TBL] [Abstract][Full Text] [Related]
17. Sensory pain qualities in neuropathic pain.
Mackey S; Carroll I; Emir B; Murphy TK; Whalen E; Dumenci L
J Pain; 2012 Jan; 13(1):58-63. PubMed ID: 22172451
[TBL] [Abstract][Full Text] [Related]
18. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin.
Vinik A; Emir B; Cheung R; Whalen E
Clin Ther; 2013 May; 35(5):612-23. PubMed ID: 23541708
[TBL] [Abstract][Full Text] [Related]
19. Oxycodone for neuropathic pain and fibromyalgia in adults.
Gaskell H; Moore RA; Derry S; Stannard C
Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
[TBL] [Abstract][Full Text] [Related]
20. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
